Deep Genomics

Deep Genomics is a company that uses artificial intelligence (AI) to develop RNA therapies for genetic diseases. The company's AI platform is designed to identify novel targets and evaluate thousands of possibilities to identify the best therapeutic candidates. Deep Genomics is currently developing BigRNA+, which will expand the number of mechanisms and genetic variants the company can pursue.

Tempus is an AI-enabled precision medicine company that brings the power of data and artificial intelligence to healthcare. With the power of AI, Tempus accelerates the discovery of novel targets, predicts the effectiveness of treatments, identifies potentially life-saving clinical trials, and diagnoses multiple diseases earlier. Tempus' innovative technology includes ONE, an AI-enabled clinical assistant; NEXT, which identifies and closes gaps in care; LENS, which finds, accesses, and analyzes multimodal real-world data; and ALGOS, algorithmic models connected to Tempus' assays to provide additional insight.

JADBio is an automated machine learning (AutoML) platform designed to accelerate biomarker discovery and drug development processes. It offers a no-code solution that automates the discovery of biomarkers and interprets their role based on research needs. JADBio can parse multi-omics data, including genomics, transcriptome, metagenome, proteome, metabolome, phenotype/clinical data, and images, enabling users to efficiently discover insights for various conditions such as cancer, immune system disorders, chronic diseases, infectious diseases, and mental health. The platform is trusted by partners in precision health and medicine and is continuously evolving to disrupt drug discovery times and costs at all stages.

VantAI is an AI application focused on generative AI-enabled drug discovery. Their mission is to unlock a new chapter in medicine by making protein interactions programmable. They have an integrated discovery platform with phase-shifting technologies designed to unlock the full potential of the proximity modulator modality. VantAI collaborates with industry leaders to build the future of therapeutic design. The company has launched Neo-1, the first AI model to rewire molecular interactions by unifying structure prediction and generation.

Valo is a company that uses AI-driven technology to transform the discovery and development of life-changing medicines. They combine machine learning, tissue biology, and patient data to create a suite of powerful capabilities that bring the future of drug discovery and development to bear. Valo's team of software engineers, data scientists, biologists, medicinal chemists, and big-picture thinkers are dedicated to advancing the combined power of technology and patient data.

Tempus is an AI-enabled precision medicine company that brings the power of data and artificial intelligence to healthcare. With the power of AI, Tempus accelerates the discovery of novel targets, predicts the effectiveness of treatments, identifies potentially life-saving clinical trials, and diagnoses multiple diseases earlier. Tempus's innovative technology includes ONE, an AI-enabled clinical assistant; NEXT, a tool to identify and close gaps in care; LENS, a platform to find, access, and analyze multimodal real-world data; and ALGOS, algorithmic models connected to Tempus's assays to provide additional insight.

Beacon Biosignals provides an EEG neurobiomarker platform that is designed to accelerate clinical trials and enable new treatments for patients with neurological and psychiatric diseases. Their platform is powered by machine learning and a world-class clinico-EEG database, which allows them to analyze existing EEG data for insights into mechanisms, PK/PD, and patient stratification. This information can be used to guide further development efforts, optimize clinical trials, and enhance understanding of treatment efficacy.

Evaxion is a pioneering TechBio company utilizing their AI-Immunology™ platform to decode the human immune system and develop novel vaccines for cancer and infectious diseases. Their platform accelerates vaccine target discovery, design, and development by simulating the human immune system and generating predictive models. Evaxion's cutting-edge research and multidisciplinary capabilities enable the rapid development of transformative treatments. The company aims to revolutionize the prevention and treatment of diseases through personalized and precision vaccines.

QuantNexus is an applied research collective that pioneers the future of molecular discovery through intelligent automation. Their mission is to empower the next generation of scientists by creating a human and AI partnership that advances biology significantly. The platform, NovoQuantNexus, fuses machine intelligence with human creativity to achieve breakthroughs in record time, outpacing conventional methods and pure-AI approaches. Researchers in pharma, biotech, and academia are leveraging this technology to accelerate discovery and redefine possibilities in life sciences.

Meta AI is a research lab dedicated to advancing the field of artificial intelligence. Our mission is to build foundational AI technologies that will solve some of the world's biggest challenges, such as climate change, disease, and poverty.

Atomwise is an AI-powered drug discovery company that uses machine learning to identify new small molecule medicines. The company's platform combines the power of convolutional neural networks with massive chemical libraries to discover new drug candidates. Atomwise has a portfolio of wholly owned and co-developed pipeline assets, and is backed by prominent investors.

JMIR AI is a new peer-reviewed journal focused on research and applications for the health artificial intelligence (AI) community. It includes contemporary developments as well as historical examples, with an emphasis on sound methodological evaluations of AI techniques and authoritative analyses. It is intended to be the main source of reliable information for health informatics professionals to learn about how AI techniques can be applied and evaluated.

Neural4D is an AI tool designed to provide advanced neural network solutions. It offers a range of features for deep learning applications, including image recognition, natural language processing, and predictive analytics. With Neural4D, users can build and train complex neural networks to solve various real-world problems. The tool is user-friendly and suitable for both beginners and experienced AI practitioners.

IKI AI is an intelligent knowledge interface that provides users with quick and easy access to information from a variety of sources. It uses natural language processing and machine learning to understand user queries and deliver relevant results. IKI AI can be used for a variety of tasks, including research, learning, and decision-making.

Practical Deep Learning for Coders is a free course designed for individuals with some coding experience who want to learn how to apply deep learning and machine learning to practical problems. The course covers topics such as building and training deep learning models for computer vision, natural language processing, tabular analysis, and collaborative filtering problems. It is based on a 5-star rated book and does not require any special hardware or software. The course is led by Jeremy Howard, a renowned expert in machine learning and the President and Chief Scientist of Kaggle.

TensorFlow is an end-to-end platform for machine learning. It provides a wide range of tools and resources to help developers build, train, and deploy ML models. TensorFlow is used by researchers and developers all over the world to solve real-world problems in a variety of domains, including computer vision, natural language processing, and robotics.

Deep Genomics is a company that uses artificial intelligence (AI) to develop RNA therapies for genetic diseases. The company's AI platform is designed to identify novel targets and evaluate thousands of possibilities to identify the best therapeutic candidates. Deep Genomics is currently developing BigRNA+, which will expand the number of mechanisms and genetic variants the company can pursue.

JADBio is an automated machine learning (AutoML) platform designed to accelerate biomarker discovery and drug development processes. It offers a no-code solution that automates the discovery of biomarkers and interprets their role based on research needs. JADBio can parse multi-omics data, including genomics, transcriptome, metagenome, proteome, metabolome, phenotype/clinical data, and images, enabling users to efficiently discover insights for various conditions such as cancer, immune system disorders, chronic diseases, infectious diseases, and mental health. The platform is trusted by partners in precision health and medicine and is continuously evolving to disrupt drug discovery times and costs at all stages.

Cradle is a protein engineering platform that uses machine learning to design improved protein sequences. It allows users to import assay data, generate new sequences, test them in the lab, and import the results to improve the model. Cradle can be used to optimize multiple properties of a protein simultaneously, and it has been used by leading biotech teams to accelerate new and ongoing projects.

PubCompare is a powerful AI-powered tool that helps scientists search, compare, and evaluate experimental protocols. With over 40 million protocols in its database, PubCompare is the largest repository of trusted experimental protocols. PubCompare's AI-powered search features allow users to find similar protocols, highlight critical steps, and evaluate the reproducibility of protocols based on in-protocol citations. PubCompare is available from any computer and requires no download.

Insitro is a drug discovery and development company that uses machine learning and data to identify and develop new medicines. The company's platform integrates in vitro cellular data produced in its labs with human clinical data to help redefine disease. Insitro's pipeline includes wholly-owned and partnered therapeutic programs in metabolism, oncology, and neuroscience.

Deep Genomics is a company that uses artificial intelligence (AI) to develop RNA therapies for genetic diseases. The company's AI platform is designed to identify novel targets and evaluate thousands of possibilities to identify the best therapeutic candidates. Deep Genomics is currently developing BigRNA+, which will expand the number of mechanisms and genetic variants the company can pursue.

BenevolentAI is a leader in applying advanced AI to accelerate biopharma drug discovery blending science and technology with a focus on finding solutions for complex diseases. We empower both biopharmaceutical companies and our internal scientists to harness the full potential of data and AI to accelerate the next generation of scientific advances. We have built our AI-enabled drug discovery engine to drive a revolution in drug discovery. The Benevolent Platform™ unlocks the power of a vast biomedical data landscape to provide a multidimensional representation of human biology across all diseases. We believe this approach will improve the probability of clinical success, and help us deliver life-changing treatments to patients – because it matters.

XtalPi is a world-leading technology company driven by artificial intelligence (AI) and robotics to innovate in the fields of life sciences and new materials. Founded in 2015 at the Massachusetts Institute of Technology (MIT), the company is committed to realizing digital and intelligent innovation in the fields of life sciences and new materials. Based on cutting-edge technologies and capabilities such as quantum physics, artificial intelligence, cloud computing, and large-scale experimental robot clusters, the company provides innovative technologies, services, and products for global industries such as biomedicine, chemicals, new energy, and new materials.

Iambic Therapeutics is a cutting-edge AI-driven drug discovery platform that tackles the most challenging design problems in drug discovery, addressing unmet patient need. Its physics-based AI algorithms drive a high-throughput experimental platform, converting new molecular designs to new biological insights each week. Iambic's platform optimizes target product profiles, exploring multiple profiles in parallel to ensure that molecules are designed to solve the right problems in disease biology. It also optimizes drug candidates, deeply exploring chemical space to reveal novel mechanisms of action and deliver diverse high-quality leads.

Tempus is an AI-enabled precision medicine company that brings the power of data and artificial intelligence to healthcare. With the power of AI, Tempus accelerates the discovery of novel targets, predicts the effectiveness of treatments, identifies potentially life-saving clinical trials, and diagnoses multiple diseases earlier. Tempus' innovative technology includes ONE, an AI-enabled clinical assistant; NEXT, which identifies and closes gaps in care; LENS, which finds, accesses, and analyzes multimodal real-world data; and ALGOS, algorithmic models connected to Tempus' assays to provide additional insight.

Bionl is a no-code bioinformatics platform designed to streamline biomedical research for researchers and scientists. It offers a full workspace with features such as bioinformatics pipelines customization, GenAI for data analysis, AI-powered literature search, PDF analysis, and access to public datasets. Bionl aims to automate cloud, file system, data, and workflow management for efficient and precise analyses. The platform caters to Pharma and Biotech companies, academic researchers, and bioinformatics CROs, providing powerful tools for genetic analysis and speeding up research processes.

Genie TechBio is the world's first AI bioinformatician, offering an LLM-powered omics analysis software that operates entirely in natural language, eliminating the need for coding. Researchers can effortlessly analyze extensive datasets by engaging in a conversation with Genie, receiving recommendations for analysis pipelines, and obtaining results. The tool aims to accelerate biomedical research and empower scientists with newfound data analysis capabilities.

HoloEye.AI is a transformative AI biological intelligence company that leverages cutting-edge artificial intelligence technology to revolutionize the field of biological research. The platform offers advanced AI solutions for analyzing complex biological data, enabling researchers to gain deeper insights and accelerate scientific discoveries.

Mapmygenome is an AI-powered platform that offers DNA testing products for health, fitness, and beauty. It provides personalized insights based on genetic analysis to help individuals make informed decisions about their health, wellness, and lifestyle choices. With over 23 years of genomics experience and the latest sequencing technology, Mapmygenome aims to empower users to take proactive steps towards improving their overall well-being.

Chemprop is a PyTorch-based framework for training and evaluating message-passing neural networks (MPNNs) for molecular property prediction. Originally developed for research purposes, Chemprop offers a comprehensive set of tools and features for training models and analyzing molecular representations. The package underwent a recent major release (v2.0.0) with significant improvements and updates.

Manifold is an AI data platform designed specifically for life sciences. It offers a collaborative workbench, data science tools, AI-powered cohort exploration, batch bioinformatics, data dashboards, data engineering solutions, access control, and more. The platform aims to enable faster collaboration and research in the life sciences field by providing a comprehensive suite of tools and features. Trusted by leading institutions, Manifold helps streamline data collection, analysis, and collaboration to accelerate scientific research.

Rationale is a cutting-edge decision-making tool powered by advanced AI technology, including the latest GPT model and in-context learning capabilities. It leverages artificial intelligence to provide users with valuable insights and recommendations for making informed decisions across various domains.

Mnemonic AI is an advanced Customer Intelligence tool that offers AI Personas and Digital Twin of the Customer. It helps organizations improve their understanding of individuals by creating data-driven buyer personas and virtual customers. The tool analyzes OCEAN Big Five Personality Traits and Schwartz Universal Values to tailor messages and marketing strategies. Mnemonic AI automates the process of creating personas and updating customer data, providing deep insights for informed decision-making.

functime is a time-series machine learning tool designed to perform forecasting at scale. It provides functions for scoring, ranking, and plotting thousands of forecasts simultaneously. With a focus on guiding users through their first end-to-end forecasting pipeline, functime serves as an AI copilot to analyze trends, seasonality, and causal factors in forecasts. The tool offers a comprehensive API reference and documentation, making it a valuable resource for both beginners and experienced analysts.

Kolank is an AI platform offering a unified API with agent interoperability, automatic model selection, and cost optimization. It enables AI agents to communicate and collaborate efficiently, providing access to a wide range of AI models for text, image, and video processing. With features like load balancing, fallbacks, and performance metrics, Kolank simplifies AI model integration and usage, making it a comprehensive solution for various AI tasks.

Promptmakr is a platform designed for buying and selling AI prompts. It serves as a marketplace where users can find and offer AI prompts for various purposes. The platform aims to connect individuals and businesses looking for AI prompts with those who create and sell them. With a user-friendly interface, Promptmakr simplifies the process of discovering, purchasing, and selling AI prompts, making it a convenient solution for both buyers and sellers in the AI industry.

StockGPT is an AI-powered financial research assistant that provides knowledge of earnings releases, financial reports, and fundamental information for S&P 500 and Nasdaq companies. It offers features like AI-powered search, customizable filters, up-to-date data, and industry research to help users analyze companies and markets more efficiently.

XenonStack is an AI application that offers a comprehensive suite of tools and services for building and managing Agentic Systems. The platform provides solutions for data management, analytics, AI transformation, and decision-making processes. With features like AI-enabled catalogs, industrial automation, and agent orchestration, XenonStack aims to empower enterprises to reimagine their business workflows and drive efficiency and agility through intelligent AI agents.

Unlearn.ai is an AI-driven platform that specializes in streamlining clinical trials through the use of AI-generated digital twins of patients. By leveraging digital twin technology and disease-specific ML models, Unlearn.ai enables researchers to design and run more efficient and impactful clinical trials across various therapeutic areas. The platform offers solutions to accelerate trial timelines, facilitate faster decision-making, and optimize trial design, ultimately enhancing trial efficiency, insights, and impact.

Discuro is an all-in-one platform designed for developers to easily build, test, and consume complex AI workflows. It integrates with GPT-3, DALLE-2, and older OpenAI models, allowing users to chain prompts together in powerful ways. With Discuro, users can define their workflows in an easy-to-use UI and execute them with a single API call. The platform enables users to build and test complex self-transforming AI workflows and data sets, monitor AI usage, and generate completions efficiently.